Rgls stock price target
Stock Comparison: Compare Regulus Therapeutics Inc. (RGLS ... Online Stock Comparison - Compare Regulus Therapeutics Inc. (RGLS) to four other stocks with NASDAQ.com's stock comparison tool. RGLS - Regulus Therapeutics Stock Price - Barchart.com 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Zacks: Analysts Anticipate Regulus Therapeutics Inc ... Wall Street analysts forecast that Regulus Therapeutics Inc (NASDAQ:RGLS) will report $5.01 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Regulus Therapeutics’ earnings, with the highest sales estimate coming in at $10.00 million and the lowest estimate coming in at $20,000.00. Regulus Therapeutics Stock Quote. RGLS - Stock Price, News ...
Regulus Therapeutics Inc Stock Quote: RGLS Stock News ...
RGLS - Regulus Therapeutics Summary, Stock Quote and News ... Jan 01, 2010 · Regulus Therapeutics (NASDAQ: RGLS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Regulus Therapeutics Inc. - RGLS - Stock Price Today - Zacks View Regulus Therapeutics Inc. RGLS investment & stock information. Get the latest Regulus Therapeutics Inc. RGLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. RGLS Stock Price and Chart — NASDAQ:RGLS — TradingView
Regulus Therapeutics Inc. Common Stock (RGLS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Regulus Therapeutics Stock Price Forecast, RGLS stock price prediction. The best long-term & short-term Regulus Therapeutics share price prognosis for 2020 , Regulus Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. RGLS updated stock price target summary.
Regulus Therapeutics Inc., RGLS Quick Chart - (NAS) RGLS ...
Zacks: Analysts Anticipate Regulus Therapeutics Inc ... Wall Street analysts forecast that Regulus Therapeutics Inc (NASDAQ:RGLS) will report $5.01 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Regulus Therapeutics’ earnings, with the highest sales estimate coming in at $10.00 million and the lowest estimate coming in at $20,000.00. Regulus Therapeutics Stock Quote. RGLS - Stock Price, News ... Regulus Therapeutics stock quote and RGLS charts. Latest stock price today and the US's most active stock market forums. Regulus Therapeutics (RGLS) stock price, charts, trades & the US's most popular discussion forums. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a RGLS Stock Price & Charts | Regulus Therapeutics Description: Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in …
Regulus Therapeutics Inc (NASDAQ:RGLS) Receives $1.31 ...
Nov 06, 2019 · 3 Wall Street analysts have issued ratings and price targets for Regulus Therapeutics in the last 12 months. Their average twelve-month price target is $1.50, suggesting that the stock has a possible upside of 215.06%. The high price target for RGLS is … RGLS Regulus Therapeutics Inc. Common Stock - NASDAQ.com Regulus Therapeutics Inc. Common Stock (RGLS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Regulus Therapeutics Inc. (RGLS) Stock Price, Quote ... Find the latest Regulus Therapeutics Inc. (RGLS) stock quote, history, news and other vital information to help you with your stock trading and investing.
RGLS | Complete Regulus Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. (RGLS) today and set a price target of $1.00 RGLS | Regulus Therapeutics Inc. Analyst Estimates ... Nov 01, 2019 · Regulus Therapeutics Inc. analyst estimates by MarketWatch. View RGLS revenue estimates and earnings estimates, as well as analyst recommendations. Alphabet stock …